mbcaUPdate


LATEST NEWS AND PATIENT RESOURCES FROM THE ALLIANCE AND OUR MEMBERS
FORCE Syndicated Content, News

Update: FDA approves new treatment for metastatic triple-negative breast cancer


Update: FDA approves new treatment for metastatic triple-negative breast cancer The FDA approved the use of sacituzumab govitecan-hizy (Trodelvy), a treatment drug for people with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. (4/27/20) Read the article Printer Friendly Page This article is most relevant for: People with

Read More

News

Topic: COVID-19 and Cancer


Topic: COVID-19 and Cancer The current COVID-19 pandemic has led to many changes in our communities. In this XRAY review we focus on the intersection between COVID-19 and cancer: who may be immunosuppressed, coping with changes in surveillance or treatment, and evaluating and dealing with media. (4/13/20) Este artículo está disponible en español. Printer Friendly

Read More

News, Publications

New Study Shows Regional Differences in Improved Survival of Patients with De Novo Metastatic Breast Cancer Over Time


In 2014, one year after its formation, the Metastatic Breast Cancer Alliance (MBC Alliance) published Changing the Landscape for People Living with Metastatic Breast Cancer. Chapter 5 of the analysis showed a lack of data about the population of metastatic breast cancer (MBC) patients living across the US. The MBC Alliance identified key questions to

Read More